Ai gen mine
Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

SRG Global (ASX:SRG) has told the market it expects FY24 earnings to be in the upper guidance range, as well as seeing a 10% jump in FY25.

The company anticipates clocking up to $99M of earnings for FY24. Strong margins were pointed to by the company on Tuesday.

Work in hand sits at $2B with a pipeline of works valued at over $6B, the company wrote. The company recently hit a 70% recurring earnings profile.

“Our FY24 financial and cash performance is clear evidence of the strength and diversity of our business which has provided both protection and opportunity in the diverse sectors and geographies in which we operate,” SRG MD David Macgeorge said.

“The Company has Record Work in Hand of $2b and is well positioned for long term sustainable growth with circa 70% annuity-style earnings and positive exposure to broader macro-economic growth drivers in a diverse range of sectors.”

The company’s full year drops on 20 August.

SRG last traded at 89cps.

SRG by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Bourse finishes week on a high as Wisetech pummeled | November 22, 2024

The ASX200 closed up 0.85% at 8,393 points. Economists increasingly expect interest rates in Australia won’t…
The Market Online Video

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing,…
Nuclear explosion mushroom cloud concept

Week 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…